Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients

AIDS Research and Human Retroviruses

Volumn 31, Issue 1, 2015, Pages 150-159

  Zanussi, Stefania ^a   Bortolin, Maria Teresa ^a   Pratesi, Chiara ^a   Tedeschi, Rosamaria ^a   Basaglia, Giancarlo ^a   Abbruzzese, Luciano ^a   Mazzucato, Mario ^a   Spina, Michele ^a   Vaccher, Emanuela ^a   Tirelli, Umberto ^a   Rupolo, Maurizio ^a   Michieli, Mariagrazia ^a   Di Mascio, Michele ^b   De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; ANTIRETROVIRUS AGENT; CARMUSTINE; CISPLATIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; MEPREDNISONE; MESNA; MITOXANTRONE; PREDNISOLONE; RITUXIMAB; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL THERAPY; ARTICLE; AUTOGRAFT; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER TRANSPLANTATION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MEDICAL HISTORY; MEMORY T LYMPHOCYTE; MIDDLE AGED; MONONUCLEAR CELL; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; VIRUS LOAD; AGED; AUTOTRANSPLANTATION; DRUG EFFECTS; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOMA, AIDS-RELATED; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PROTEASE INHIBITORS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; TRANSPLANTATION, AUTOLOGOUS; VIRAL LOAD;

EID: 84937153292     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0157     Document Type: Article

References (47)

1. High KP, Brennan-Ing M, Clifford DB, et al.: HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012;60(Suppl 1):S1-18
2. Apostolova N, Blas-García A, and Esplugues JV: Mitochondrial toxicity in HAART: An overview of in vitro evidence. Curr Pharm Des 2011;17:2130-2144
3. Deeks SG: HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011;62:141-155
4. International AIDS Society Scientific Working Group on HIV Cure, Deeks SG, Autran B, Berkhout B, et al.: Towards an HIV cure: A global scientific strategy. Nat Rev Immunol 2012;12:607-614
5. Hütter G, Nowak D, Mossner M, et al.: Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. N Engl J Med 2009;360:692-698
6. Deeks SG and Walker BD: Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007;27: 406-416
7. Van Gulck E, Bracke L, Heyndrickx L, et al.: Immune and viral correlates of secondary viral control after treatment interruption in chronically HIV-1 infected patients. PLoS One 2012;7:e37792
8. Mendoza D, Johnson SA, Peterson BA, et al.: Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood 2012;119:4645-4655
9. Kitchen SG and Zack JA: Stem cell-based approaches to treating HIV infection. Curr Opin HIV AIDS 2011;6:68-73
10. Woolfrey AE, Malhotra U, Harrington RD, et al.: Generation of HIV-1-specific CD8 + cell responses following allogeneic hematopoietic cell transplantation. Blood 2008; 112:3484-3487
11. Henrich TJ, Hu Z, Li JZ, et al.: Long-term reduction in peripheral blood HIV type 1 reservoirs following reducedintensity conditioning allogeneic stem cell transplantation. J Infect Dis 2013;207:1694-1702
12. Henrich T, Hanhauser E, Sirignano M, et al.: In depth investigation of peripheral and gut HIV-1 reservoirs, HIV-specific cellular immunity, and host microchimerism following allogeneic hematopoietic stem cell transplantation [Abstract WELBA05]. In Program and Abstract book from the International AIDS Society 7th Conference on HIV Pathogenesis and Prevention, June 30-July 3, 2013, Kuala Lumpur, Malaysia
13. Cillo AR, Krishnan A, Mitsuyasu RT, et al.: Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J Acquir Immune Defic Syndr 2013;63:438-441
14. Simonelli C, Zanussi S, Pratesi C, et al.: Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Clin Infect Dis 2010;50: 1672-1679
15. Resino S, Pérez A, Seoane E, et al.: Short communication: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: Might be better than expected?. AIDS Res Hum Retroviruses 2007;23: 543-548.
16. Mavigner M, Watkins B, Lawson B, et al.: Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant. PLoS Pathog 2014;10:e1004406
17. DiGiusto DL, Krishnan A, Li L, et al.: RNA-based gene therapy for HIV with lentiviral vector-modified CD34( + ) cells in patients undergoing transplantation for AIDSrelated lymphoma. Sci Transl Med 2010;2:36ra43
18. Tebas P, Stein D, Tang WW, et al.: Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 2014;370:901-910
19. Pace M and ODoherty U: Hematopoietic stem cells and HIV Infection. J Infect Dis 2013;207:1790-1792
20. Josefsson L, Eriksson S, Sinclair E, et al.: Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 2012;206:28-34
21. Durand CM, Ghiaur G, Siliciano JD, et al.: HIV-1 DNA is detected in bone marrow populations containing CD4 + T cells but is not found in purified CD34 + hematopoietic progenitor cells in most patients on antiretroviral therapy. J Infect Dis 2012;205:1014-1018
22. Abbruzzese L, Michieli M, Rupolo M, et al.: A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: A single institution experience. Vox Sang 2010;98:172-180
23. Keeney M, Chin-Yee I, Weir K, et al.: Single platform flow cytometric absolute CD34 + cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998;34:61-70
24. Zanussi S, Vaccher E, Caffau C, et al.: Interferon-gamma secretion and perforin expression are impaired in CD8 + T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2003; 52:28-32
25. Bortolin MT, Zanussi S, Talamini R, et al.: Predictive value of HIV type 1 DNA levels on overall survival in HIV-related lymphoma patients treated with high-dose chemotherapy (HDC) plus autologous stem cell transplantation (ASCT). AIDS Res Hum Retroviruses 2010;26:245-251
26. Viard JP, Burgard M, Hubert JB, et al.: Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 2004; 18:45-49
27. Bortolin MT, Pratesi C, Dolcetti R, et al.: Clinical value of Epstein-Barr virus DNA levels in peripheral blood samples of Italian patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Lett 2006;233:247-254
28. Michieli M, Mazzucato M, Tirelli U, and De Paoli P: Stem cell transplantation for lymphoma patients with HIV infection. Cell Transplant 2011;20:351-370
29. Savkovic B, Macpherson JL, Zaunders J, et al.: T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals. Clin Immunol 2012;144:159-171
30. Mackall C, Fry T, Gress R, et al.: Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant 2009;44:457-462
31. Surh CD and Sprent J: Homeostasis of naive and memory T cells. Immunity 2008;29:848-862
32. Sasson SC, Zaunders JJ, Seddiki N, et al.: Progressive activation of CD127 + 132 - recent thymic emigrants into terminally differentiated CD127 - 132 + T-cells in HIV-1 infection. PLoS One 2012;7:e31148
33. Zaunders JJ, Ip S, Munier ML, et al.: Infection of CD127 + (interleukin-7 receptor + ) CD4 + cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol 2006;80:10162-10172
34. Vandergeeten C, Fromentin R, DaFonseca S, et al.: Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood 2013;121:4321-4329
35. Uchida N, Bonifacino A, Krouse AE, et al.: Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34 + cells mobilized by G-CSF and plerixafor. Exp Hematol 2011;39: 795-805
36. Benicchi T, Ghidini C, Re A, et al.: T-cell immune reconstitution after hematopoietic stem cell transplantation for HIVassociated lymphoma. Transplantation 2005;80:673-682
37. Talmadge JE, Reed E, Ino K, et al.: Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997;19:161-172
38. Krause SW, Rothe G, GnadM, et al.: Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation. Ann Hematol 2003;82:628-636
39. Chomont N, El-Far M, Ancuta P, et al.: HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009;15:893-900
40. Shan L, Deng K, Shroff NS, et al.: Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 2012;36:491-501
41. Weiss RA: Immunotherapy for HIV infection. N Engl J Med 2014;370:379-380
42. Re A, Cattaneo C, Skert C, et al.: Stem cell mobilization in HIV seropositive patients with lymphoma. Haematologica 2013;98:1762-1768
43. MacEneaney OJ, Connick E, and DeSouza CA: Effects of HIV-1 gp120 and protease inhibitors on apoptotic susceptibility of CD34 + hematopoietic progenitor cells. J Acquir Immune Defic Syndr 2011;56:e49-50
44. Isgrò A, Leti W, De Santis W, et al.: Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4 + T cell counts despite viral suppression during HAART. Clin Infect Dis 2008;46:1902-1910
45. Gómez-Garre D, Estrada V, Ortega-Hernández A, et al.: Association of HIV-infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis. J Acquir Immune Defic Syndr 2012;61:545-551
46. Witzens-Harig M, Heilmann C, Hensel M, et al.: Longterm follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34 + -selected peripheral blood progenitor cells. Stem Cells 2007;25:228-235
47. Schwinger W, Weber-Mzell D, Zois B, et al.: Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Br J Haematol 2006;135:76-84